Catalyst Wire Dossier Catalyst Wire Dossier

olodaterol

olodaterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for olodaterol, covering 2011-11-22 to 2021-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale [Phase 4]

See pricing